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A Novel Adaptor Protein Orchestrates Receptor
Patterning and Cytoskeletal Polarity
in T-Cell Contacts
with an outer ring of LFA-1 surrounding an inner circle
containing TCR (Monks et al., 1998). The exact function
is unclear, but several features are consistent with re-
ceptor patterning playing a role in facilitating TCR en-
gagement. First, including the TCR in a central cluster
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ability of TCRs to engage rare ligand molecules. Lastly,
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for cytoskeletal polarity. Cell polarity allows cytotoxicSummary
agents and cytokines to be focused directly at the cell
in contact.
Recognition of antigen by T cells requires the forma- Surprisingly, the mechanism of molecular patterning
tion of a specialized junction between the T cell and and cytoskeletal polarization in the junction between T
the antigen-presenting cell. This junction is generated cells and antigen-presenting cells is unknown. We have
by the recruitment and the exclusion of specific pro- begun to analyze this process by studying the T-cell
teins from the contact area. The mechanisms that reg- membrane protein CD2, a 50 kDa protein expressed on
ulate these events are unknown. Here we demonstrate the surface of T lymphocytes and natural killer (NK) cells.
that ligand engagement of the adhesion molecule, Although heavily studied in the last 15 years, the exact
CD2, initiates a process of protein segregation, CD2 function of CD2 is still unclear. But its expression on T
clustering, and cytoskeletal polarization. Although and NK cells suggests that it plays an important role in
protein segregation was not dependent on the cyto- the biology of these cells.
plasmic domain of CD2, CD2 clustering and cytoskele- Because it is an adhesion molecule that binds specific
tal polarization required an interactionof the CD2 cyto- ligands expressed on a wide range of APCs, CD2 is
plasmic domain with a novel SH3-containing protein. well-positioned to participate in contact area formation.
This novel protein, called CD2AP, is likely to facilitate In humans, the principle ligand for CD2 is CD58 (Shaw
receptor patterning in the contact area by linking spe- et al., 1986). In rodents, the related molecule CD48 is
the ligand for CD2 (Davis and van der Merwe, 1996).cific adhesion receptors to the cytoskeleton.
Receptor±ligand interactions in this system are species
specific since human CD2 does not bind rodent CD48Introduction
and rat CD2 does not bind human CD58. The complex
of CD2 bound to its ligand spans a gap of 15 nm (vanT-cell activation requires T-cell antigen receptor (TCR)
der Merwe et al., 1995), suggesting that CD2 adhesionrecognition of peptides bound to MHC molecules (anti-
might serve to solve a topological problem inherent ingen). The physical dimensions of the TCR interacting
TCR recognition of ligand. The formation of a junctionwith antigen suggest that TCR recognition will require
using adhesion molecules that are similar in size to thethe formation of a narrow 15 nm gap between the T cell
TCR would clearly facilitate engagement of MHC byand antigen-presenting cell membranes (Garboczi et al.,
the TCR.1996; Garcia et al., 1996). Because the affinity of the
When plated on its ligand, CD2 concentrates andTCR for antigen is very low, on the order of 1024±1026
forms a small junction in which thousands of CD2±CD58M (Corr et al., 1994; Matsui et al., 1994), and the number
interactions cooperate to closely align the T cell andof ligands is likely to be limited, the interaction of the
APC membranes (Dustin et al., 1997b). Because it isTCR with antigen seems unlikely to be sufficient to drive
associated with the TCR, CD2 clustering could alsoformation of this tight contact (Davis and van der Merwe,
serve to recruit the TCR to the contact surface (Bocken-
1996; Shaw and Dustin, 1997). Other mechanisms must
stedt et al., 1988; Beyers et al., 1992). Concentrating the
therefore exist to initiate and stabilize the cell±cell
TCR along with associated molecules like CD2, CD4,
contact. CD8, and CD28 in two-dimensional space could gener-
One of these mechanisms is the use of adhesive mole- ate enough attractive force to stabilize the interaction
cules to form a specialized junction between the T cell between the two cells as well as to force larger proteins
and the antigen-presenting cell (APC). An important fea- to the periphery of the contact.
ture of this junction is a specific pattern of receptors In this study, we investigated the process of CD2
clustering stimulated by ligand binding and T-cell activa-
tion. We found that CD2 binding to ligand stimulates§To whom correspondence should be addressed.
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Figure 1. Comparison of Integrin Spreading
and CD2 Concentration in T-Cell Bilayer
Junctions
Jurkat T cells expressing wild-type rat CD2
were treated with 10 ng/ml PMA and 1 mM
ionomycin and were plated on planar bilayers
with ICAM-1 (A) or FITC-CD48 (B and C). In
(A) and (B) the junctions, as visualized by IRM,
are dark. (C) shows FITC-CD48 concentration
in the junctions. Next, the rat CD2 Jurkat cells
were activated as above and plated on bi-
layers containing TRITC-ICAM-1 and FITC-
CD48. (D) shows the junction, (E) shows the
superposition of FITC-CD48 concentration
on the junction, and (F) shows the exclusion
of ICAM-1 from the areas of FITC-CD48 accu-
mulation. ICAM-1 monomers do not bind
strongly enough to LFA-1 to be concentrated
in the contact areas. (G), (H), and (I) are the
same as (D), (E), and (F), respectively, except
that the C-terminal 20 amino acids are de-
leted from the rat CD2 (CY97).
clustering of CD2 and also polarization of the T cell. receptor engagement on LFA-1 and CD2 avidity (Dustin
and Springer, 1989; Hahn et al., 1992). Previously, it hadClustering and polarization required the CD2 cyto-
plasmic domain as cells expressing forms of CD2 that been shown that engagement of LFA-1 or CD2 elicit
distinct T-cell behaviors (Dustin and Springer, 1988).lack the cytoplasmic domain were unable to cluster
CD2 or to polarize. These processes are mediated by When T cells are plated on lipid bilayers containing
ICAM-1, the ligand for LFA-1, the cells spread, formingthe binding of a novel SH3-containing protein that
binds to the cytoplasmic domain of CD2. Binding of this a large broad junction as visualized by interference re-
flection microscopy (IRM, Figure 1A). In contrast, whennovel protein, called CD2-associated protein (CD2AP),
to CD2 is induced by T-cell activation and is required T cells are plated on lipid bilayers containing CD58, the
ligand for human CD2, cells round up and CD2 clusters,for CD2 clustering and T-cell polarization. Thus, CD2AP
seems likely to function as a molecular scaffold for re- forming a small, discrete junction (Figures 1B and 1C).
We next tested the behavior of Jurkat T cells on lipidceptor patterning and cytoskeletal polarization. Both of
these events are critical to the formation of an effective bilayers containing fluorescently labeled CD48 (green)
and ICAM-1 (red). Areas of CD48 concentration withinT-cell±antigen-presenting cell junction.
the contact mark the sites of CD2 engagement. Acti-
vated Jurkat T cells expressing full-length rat CD2 wereResults
plated on the lipid bilayer. IRM demonstrated that T cells
plated on a bilayer containing both ligands form a broadCD2 and LFA-1 Have Distinct Roles
contact typical of cells plated on ICAM-1 (Figure 1D).in Contact Formation
Visualization of CD48 accumulation demonstrated thatTo study the mechanisms that regulate formation of the
CD2 engagement is biased to the center of the contactjunction between a T cell and an antigen-presenting cell,
(Figure 1E). Furthermore, ICAM-1 molecules are ex-we began by determining whether we could simulate
cluded from the sites of CD2 engagement (Figure 1F).antigen-specific junction formation using purified li-
Thus, key elements of receptor patterning observed ingands for CD2 and LFA-1 embedded into lipid bilayers.
T cell±antigen-presenting cell contactscan be simulatedBecause the two major adhesive proteins on the T-cell
using artificial lipid bilayers containing the ligands forsurface are LFA-1 and CD2 (Shaw et al., 1986), we rea-
CD2 and LFA-1. Receptor patterning was dependent onsoned that they are likely to be involved in generating
T-cell activation as only broad CD2-mediated contactsthe junction between T cells and APCs. T cells were
were formed when cells were plated without prior stimu-treated with phorbol ester and calcium ionophore before
plating on the substrate to simulate the effects of antigen lation with PMA and ionomycin.
Receptor Patterning in T-Cell Contacts
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Figure 2. CD2 Concentration Requires the Last 20 Amino Acids of
the Cytoplasmic Domain
Jurkat cells transfected with full-length rat CD2 (FL, panel A), rat
CD2 with a 97±amino acid cytoplasmic domain (CY97, panel B), or
rat CD2 with a 6±amino acid cytoplasmic domain (CY6, panel C)
were treated with PMA and ionomycin and plated on 600 molecules/
mm2 of CD48 embedded in glass-supported planar bilayers. After
60 min at 378C the cells were fixed and observed by IRM. The gray
IRM images were used to generate the black segments shown. The
average areas of greater than 100 contacts for each cell type are
summarized in (D). These data are representative of three experi-
ments.
Clustering and Segregation of CD2 Requires Figure 3. The Cytoplasmic Domain of CD2 Regulates Cytoskeletal
Its Cytoplasmic Domain Polarity
To determine the molecular basis for CD2 clustering Jurkat T cells expressing wild-type rat CD2 (FL, panel A), rat
CD2 with a 97±amino acid cytoplasmic tail (CY97, panel B), or ratafter contact formation, we began by testing whether
CD2 with a 6±amino acid cytoplasmic tail (CY6, not shown) werethe cytoplasmic domain of CD2 was required. Jurkat
treated with PMA and ionomycin and incubated on planar bilayerscells stably transfected with either full-length rat CD2
containing 1000 molec/mm2 of mouse or rat CD48. Cells were treatedor forms of CD2 lacking either the complete cytoplasmic
with 10 ng/ml PMA and 1 mM ionomycin. After 60 min the cells were
domain (CY6) or the 20 C-terminal residues (CY97) were fixed and the position of the MTOC determined by fluorescence
activated and tested for their ability to cluster CD2 by microscopy. (C) indicates the criteria for scoring a cell as polarized.
This cylindrical volume represents approximately 1% of the cyto-measuring contact size (He et al., 1988; Figure 2). The
plasmic volume such that this positioning of the MTOC is unlikelyuse of rat CD2 allowed us to distinguish mutated CD2
to occur at random. The data in (D) are from two experiments.molecules from the wild-type human CD2 present in
Jurkat cells. Unlike cells expressing wild-type CD2, T
cells expressing either of the two truncated forms of CD2
localization of CD2 requires the C-terminal 20 residuesformed larger, more heterogeneous junctions (Figure 2).
of CD2.This suggested that the last 20 residues of the cyto-
plasmic domain of CD2 were required for the normal
regulation of CD2 junction size. The Cytoplasmic Domain of CD2 Can
Mediate T-Cell PolarizationWe next tested the ability of mutated forms of CD2
to segregate in the center of the junction when plated Because contact formation is the first step in cell polar-
ization, we tested whether T-cell activation and CD2on lipid bilayers containing both CD48 and ICAM-1. CD2
molecules lacking the complete cytoplasmic domain clustering might be sufficient to induce T-cell polariza-
tion. Polarization of T cells is characterized by the move-(data not shown) or the C-terminal 20 residues did not
concentrate at the center of the contact, but rather were ment of the Golgi complex and the microtubule-organiz-
ing center (MTOC) to a region of the cytoplasm justdistributed throughout the entire contact (Figure 1 H).
Visualization of ICAM-1 demonstrated that it was still adjacent to the area of contact (Kupfer et al., 1986). T
cells expressing wild-type or truncated forms of CD2excluded from contact areas containing engaged CD2
(Figure 1I). This suggests that extracellular CD2 engage- were plated on CD48, fixed, and then stained with anti-
tubulin to mark the position of the MTOC. The MTOCment is primarily responsible for ICAM-1 exclusion and,
consistent with our topological model, that CD2/CD48 was then visualized by optical sectioning microscopy
(Figures 3A and 3B), and cells were scored positive forand LFA-1/ICAM interactions are mutually exclusive
(Shaw and Dustin, 1997). Our data therefore suggest polarization if the MTOC was visible within 1 mm of the
planar bilayer and 1 mm of the contact center (Figurethat initial segregation of adhesion molecules in contact
areas is mediated by size incompatibility, but the central 3C). Greater than 80% of the cells expressing wild-type
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CD2 were polarized, but significantly fewer cells ex-
pressing either of the cytoplasmic truncations of CD2
were polarized (Figure 3D). This establishes that the last
20 residues of the CD2 cytoplasmic domain are required
for CD2 clustering and T-cell polarization and suggests
that both processes may be linked.
Identification of a Novel SH3-Containing
Protein that Interacts with the
Cytoplasmic Tail of CD2
Examination of the last 20 residues of CD2 demonstrates
the presence of multiple proline residues that could
serve as ligands for conserved protein binding modules
such as SH3 domains. SH3 domains are found in a wide
variety of signaling and cytoskeletal proteins and bind
proline-rich sequences. We used the yeast two-hybrid
screen to identify CD2-interacting proteins (Fields and
Song, 1989; Vojtek et al., 1993). From a mouse embryo
library, a partial cDNA encoding a novel SH3 domain
was identified. The protein bound specifically to CD2
as expression of the DNA-binding domain of LexA alone
or a control fusion protein, LexA-lamin,did not transacti-
vate the reporter construct (data not shown).
A full-length cDNA was obtained by screening a cDNA
library from mouse thymus. The deduced amino acid
sequence predicts a 641 amino acid protein with a mo-
lecular weight of approximately 70 kDa (Figure 4A) con-
taining three SH3 domains in the amino-terminal half of
Figure 4. A Novel SH3 Domain-Containing Protein Identified in the
the protein. The SH3 domain cloned using the yeast Yeast Two-Hybrid Screen using the Cytoplasmic Domain of CD2
two-hybrid screen represented the most amino-terminal
(A) Sequence of a novel triple SH3 domain±containing protein
of the three SH3 domains. The sequence of the latter (CD2AP) identified using the two-hybrid screen using the one-letter
half of the protein is proline-rich and contains some amino acid code. SH3 domains are boxed. Proline-rich stretches
are underlined. A putative C-terminal monomeric b-Thymosin-likesequence similarity to neurofilament proteins as well as
actin binding domain is doubly underlined. Psi-Blast analysisa recently cloned myosin I-binding protein, Acan125,
(Altschul et al., 1997) of the second half of this sequence demon-from Acanthamoeba (Xu et al., 1995). A possible role for
strated similarities with intermediate filaments and with a myosin
CD2AP in binding actin is suggested by the presence I±binding protein (Xu et al., 1995).
at the C terminus of a sequence similar to the monomeric (B) Multiple tissue Northern blotting analysis of CD2AP. A commer-
actin±binding protein, thymosin-b4, (Van Troys et al., cial membrane was hybridized with a labeled CD2AP DNA probe.
Tissue types: H, heart; B, brain; S, spleen; Lu, lung; Li, liver; SM,1996). Because of its identification as a CD2-binding
smooth muscle; K, kidney; T, thymus; J, jurkat; Th, T helper clone;protein, the protein is named CD2-associated protein
NK, natural killer cell line; H, HeLa.or CD2AP.
(C) Immunoblotting analysis of CD2AP protein expression in various
Northern blotting studies performed to analyze tissue tissues and cell lines. Mouse tissues (lanes 1±7) and cell lysates
distribution (Figure 4B) detected message in all tissues (lanes 8±11) were probed with a rabbit polyclonal anti- CD2AP sera,
tested except brain. The pattern of protein expression followed by a secondary HRP-conjugated antibody and developed
using chemiluminescence. Tissue andcell types are indicated abovewas verified using a rabbit polyclonal antiserum. Immu-
each lane.noblotting of multiple tissues demonstrated that the an-
tiserum recognized an approximately 80 kDa protein
between CD2 and the CD2AP could be reconstituted infrom liver, thymus, and spleen (Figure 4C). No protein
HeLa cells. The CD2AP cDNA was tagged with a mycwas detected in brain, kidney, or lung. It is not clear
what explains the discrepancy between the Northern epitope (Evan and Bishop, 1985) while CD2 was ex-
and Western blotting. Although the protein mobility is pressed as a chimera with the extracellular and trans-
slower than predicted based on the protein sequence, membrane domains of the viral glycoprotein VSV-G. The
it is similar to the mobility of protein expressed from the proteins were coexpressed in HeLa cells and complex
full-length cDNA (Figure 5). Immunoblotting of lysates formation was tested by analyzing VSV G/CD2 immuno-
from cell lines confirmed that the protein is expressed precipitates for coprecipitating CD2AP (Figure 5B). Both
abundantly in cells known to express CD2 such as T full-length CD2AP, which has a molecular mobility of
cells and NK cells (Figure 4C). It was also expressed in approximately 80 kD, and the first CD2AP SH3 domain
fibroblast cell lines. alone were coprecipitated efficiently with the G/CD2
chimeric protein (Figures 5B and 5C, lane 2). This was
specific because no association was detected whenThe First SH3 Domain of CD2AP Binds to a Proline
Sequence at the C Terminus of CD2 CD2AP was coexpressed with a construct that contains
only the extracellular and transmembrane domains ofTo define the features of CD2AP and CD2 that mediate
their interaction, we first tested whether the interaction VSV G, G T2 (Figures 5B and 5C, lane 1).
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for complex formation. Deletion of P1 or P2 alone or
together had no effect on the ability of CD2 to coprecipi-
tate with CD2AP (Figure 5B, lane 3 and data not shown).
Deletion of P3, however, completely abrogated the abil-
ity of CD2 to coprecipitate CD2AP (Figure 5B, lane 4).
Therefore, CD2AP interacts with a proline-rich sequence
contained within the last 30 residues of the cytoplasmic
domain of CD2.
Three overlapping 20-mer peptides based on the last
30 residues of CD2 were generated and tested for bind-
ing using surface plasmon resonance (SPR). Only one
peptide containing the amino-terminal 20 of the last 27
residues of the CD2 cytoplasmic domain was sufficient
for binding (see below and data not shown). Mutagene-
sis data demonstrated that the primary binding site is
a Type II SH3 ligand (PPLPRPR) and five to seven
C-terminal flanking residues to the motif are required
for binding (data not shown). Thus, CD2AP binding to
CD2 requires sequences that are lacking in the CY97
form of CD2.
Cloning of the first SH3 domain of CD2AP in the origi-
nal yeast screen demonstrated that it was sufficient by
itself to mediate the interaction between CD2 and
CD2AP. However, the presence of multiple proline-rich
segments in CD2 and multiple SH3 domains in CD2AP
suggested that other interactions between CD2 and
CD2AP might also occur. We tested this by generatingFigure 5. Mapping the Interaction between CD2AP and CD2
a construct that lacks the first SH3 domain of CD2AP,
(A) Schematic diagram of VSV-G-CD2 constructs used to map the
DSH3#1, and expressing it with G/CD2 (Figure 5C, lanesinteraction between SH3±1 of CD2AP with murine CD2. The proline-
3 and 4). No DSH3#1 could be detected in the G/CD2rich sequences are represented by the gray and open boxes.
immunoprecipitates. The interaction between CD2 and(B) CD2AP binds to a proline-rich region at the C terminus of the
CD2 cytoplasmic domain. The first CD2AP SH3 domain was ap- CD2AP is therefore mediated solely by the first SH3
pended with the myc epitope and coexpressed with VSV-G/CD2 domain of CD2AP.
constructs lacking either P1 and P2 or the P3 proline sequences
using the vaccinia-T7 expression system in HeLa cells. VSV-G
constructs were immunoprecipitated, separated by SDS-PAGE, The Association of CD2AP with CD2 in T Cells
transferred, and blotted with anti-myc followed by a secondaryHRP- Is Activation Dependent
conjugated antibody, and developed using chemiluminescence. To determine whether CD2AP associates with CD2 in T
Immunoblotting of cell lysates to control for expression of myc-
cells, CD2 immunoprecipitates from Jurkat T cells wereCD2AP (middle panel) and VSV G (lower panel) are shown.
immunoblotted with antibodies against CD2AP. From(C) Only the first SH3 domain of CD2AP binds to CD2. The VSV
unstimulated T cells, CD2 immunoprecipitates con-G/CD2 chimera (lanes 2 and 4) was coexpressed with either full-
length myc-CD2AP (lanes 1 and 2) or with a myc-CD2AP construct tained a small amount of CD2AP (Figure 5D, lane 1).
lacking the first SH3 domain (lanes 3 and 4). A VSV-G tail minus However, several different methods of activating T cells
construct, T2 (lanes 1 and 3), was used as a control. The VSV-G strongly induced the association of CD2AP with CD2.
immunoprecipitates were separated by SDS-PAGE and immu-
Phorbol ester and ionophore treatment, which can to-noblotted following transfer to nitrocellulose using a monoclonal
gether activate T cells, strongly enhanced CD2/CD2APantibody to the myc epitope tag. The proteins were visualized using
association (Figure 5D, lane 4). But treatment with eithera secondary HRP-conjugated antibody and chemiluminescence.
Expression controls for myc-CD2AP (middle panel) and for VSV G agent alone had only a small effect on the association
(lower panel) are shown. of CD2 with CD2AP (Figure 5D, lanes 2 and 3). T cells
(D) Activation-dependent association between CD2 and CD2AP in can also be activated by ligation of CD2 with specific
Jurkat T cells. Jurkat T cells were treated with PMA (P), Ionomycin
pairs of CD2 monoclonal antibodies (Olive et al., 1986).(I), PMA 1 Ionomycin (P&I), with an activating pair of CD2 antibodies
Treatment of T cells with such a pair of CD2 monoclonal(Ab), or left untreated (C). Cells were lysed and immunoprecipitates
antibodies (CD2.1 and TS2/18) significantly augmentedprepared with antibodies to CD2, separated by SDS-PAGE, trans-
ferred to nitrocellulose, and developed with polyclonal antibodies the amount of CD2AP associated with CD2 (Figure 5D,
to CD2AP. lane 5). As expected, treatment with either of the anti-
CD2 antibodies alone had no effect on the association
(data not shown). The association of CD2AP with CD2To define the segment of CD2 that interacts with
is therefore regulated by T-cell activation.CD2AP, we focused on proline-rich sequences because
they are known to bind to SH3 domains (Ren et al.,
1993). We focused onthree proline-rich segments desig- The CD2AP SH3 Domain Binds to CD2
with High Affinity and Specificitynated in Figure 5A as P1, P2, and P3. G/CD2 constructs
that lacked each of the proline sequences were coex- Using surface plasmon resonance, the affinity of the
first CD2AP SH3 domain for CD2 was measured. A GSTpressed with the first SH3 domain of CD2AP and tested
Cell
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to either the peptide or the SH3 domain, we compared
the ability of a wide variety of SH3 domains to bind to
the CD2 peptide (Figure 6B). Each of the SH3 proteins
was purified as a GST fusion protein and binding was
compared at a concentration of 1 mM by SPR. At this
concentration, only the CD2AP SH3 domain exhibited
significant binding. Direct affinity measurements of the
Fyn and Lck SH3 domains for the CD2peptide generated
affinity values of 15±20 mM, consistent with those pre-
viously reported for SH3 domains from Src kinases
(Rickles et al., 1995).
A Dominant-Negative Form of CD2AP Disrupts
Receptor Patterning and Cell Polarization
To confirm the involvement of CD2AP, we tested
whether a truncated form of CD2AP could block recep-
tor patterning by inhibiting wild-type CD2AP binding to
CD2. A chimeric protein was generated consisting of
the first two SH3 domains of CD2AP fused to green
fluorescent protein (GFP). We reasoned that this protein
should bind constitutively to CD2, but might inhibit
CD2AP function because it lacks most of the other pro-
tein-binding motifs of wild-type CD2AP. The chimera,
CD2AP SH3-GFP, was transiently expressed in Jurkat
T cells. T cells were plated on lipid bilayers containing
ICAM-1 and CD58 24±30 hr after transfection. As GFP
fluorescence is similar to fluorescein, CD58 was labeled
with TRITC (yellow in Figure 7) and ICAM-1 was labeled
with Cy5 (red in Figure 7). Visualization of LFA-1 engage-
ment was enhanced by using ICAM-1 dimers with higher
Figure 6. CD2AP Binds to CD2 with High Specificity and High Af-
affinity for LFA-1 (Miller et al., 1995). A construct con-finity
taining the SH3 domain of Fyn fused to GFP was used(A) Scatchard analysis for the binding of the first SH3 domain of
as a control (Figures 7G-7I).CD2AP to a CD2 peptide measured by surface plasmon resonance.
Cells expressing the CD2AP SH3-GFP chimera dis-A peptide corresponding to CD2 residues 302±322 was biotinylated
and bound to a streptavidin sensor chip. CD2AP SH3±1-GST was rupted CD2 recruitment to the center of the contact
flowed over the chip at various concentrations and the change in (Figure 7). In most of the cells, junctions were disorga-
surface plasmon resonance measured. Response units (RU) were nized with no clear central patterning of CD2 (Figure
measured after equilibrium binding and after correction for bulk
7C). Interestingly, a significant proportion of junctionseffects of background. A representative experiment is shown of five
from CD2AP SH3-GFP±expressing cells showed centraltrials. The calculated Kd of the above experiment is 194 nM with an
clusters of LFA-1 surrounded by a ring of CD2 engage-r2 of 0.931. Values obtained in other experiments ranged from 150
to 194 nM. ment (Figures 7D±7F).
(B) Various SH3-GST fusion proteins (1 mM) were flowed over a We next tested whether CD2AP-GFP protein could
sensor chip bound with a CD2 peptide corresponding to residues inhibit cytoskeletal polarization. Expression of the CD2AP
317±337. Binding was measured using surface plasmon resonance.
SH3-GFP chimera strongly inhibited the ability of CD2The data are an average of three experiments and are presented
to stimulate T-cell polarization as compared to untrans-as percent of binding compared to the binding of a GST fusion
fected T cells or cells transfected with the Fyn-GFPprotein containing either the single SH3 domain or full-length
CD2AP. chimera (Figures 7J±7L). These data support the idea
that CD2AP binding to CD2 mediates the ability of CD2
to induce T-cell polarization and receptor patterning.fusion protein containing the first SH3 domain was puri-
fied and its affinity towards a CD2 peptide (residues
317±337) was determined by measuring the kinetics of Antigen Receptor Engagement Triggers
CD2 Clusteringbinding as well as by Scatchard analysis. The kon and
koff rates were determined to be 3.5 3 103 s/M and 3.8 3 In the foregoing experiments we utilized phorbol esters
and calcium ionophore to simulate antigen receptor en-1024/s, giving a Kd of 130 nM for the interaction between
CD2 and CD2AP. Scatchard analysis gave comparable gagement. Without prior activation, receptor patterning
and polarity was not detected using Jurkat T cells. Tovalues for the Kd of between 150 and 190 nM (Figure
6A). This is an extremely high affinity for an SH3 domain confirm that receptor patterning and CD2 clustering
were dependent on antigen receptor engagement, weas most SH3 interactions are in the 10±20 mM range.
But it is comparable to an affinity recently reported for used T cells from 3A9 TCR transgenic mice that recog-
nize the MHC molecule I-Ak complexed with peptidethe SH3 domain of a Rho GTP exchange factor, PIX, to
PAK kinase (Manser et al., 1998). 48±62 from hen egg lysozyme (I-AkzHEL48±62) pre-
sented by supported planar bilayers (Dustin et al.,To determine whether this high affinity was intrinsic
Receptor Patterning in T-Cell Contacts
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Figure 7. Dominant Negative CD2AP Inhibits
Receptor Patterning and Cytoskeletal Po-
larity
Jurkat T cells transiently expressing the two
amino-terminal SH3 domains of CD2AP fused
to GFP (CD2AP SH3-GFP) (A-F, J, and K) or
with GFP fused to the SH3 domain of Fyn
(Fyn SH3-GFP) (G-I) were treated with PMA
and ionomycin and plated on planar bilayers
with TRITC-CD58 (yellow) and Cy5 ICAM-1
dimers (red) (A-I) or on unlabeled CD58. After
1 hr at 378C the cells were fixed and stained
for tubulin (J and K). The GFP-expressing
cells were identified by green fluorescence
(A, D, G, and J) and junctions were defined by
IRM (B, E, and H). In (C), (F), and (I), receptor
patterning is visualized as areas of discrete
LFA-1/ICAM-1 engagement (red) and CD2/
CD58 engagement (yellow). The pattern of
CD2 engagement is disorganized (C) or com-
pletely inverted (F) in the CD2AP-GFP-posi-
tive cells, but is not affected in Fyn SH3-GFP
cells (I). In (K) the positions of the MTOC
within 1 mm of the substrate are indicated
with arrows. Polarity data from 3 experiments
with at least 30 GFP-positive cells are sum-
marized in (L).
1997a). The 3A9 T cells were plated on bilayers with required for physiological formation of CD2 clusters and
for receptor patterning.ICAM-1 and FITC-CD48, with and without I-AkzHEL48±
62. In the absence of antigen the T cells crawled on
the substrate and relatively little CD2 engagement was Discussion
detected based on imaging CD48 redistribution (Figure
8A). The presence of a low amount of I-AkzHEL48±62 The ability of antigen-specific T cells to locate and grasp
target cells that express specific peptide/MHC com-in the bilayer resulted in a 13- to 14-fold increase in CD2
engagement and formation of pronounced CD2 clusters plexes involves an ordered and complex series of events
that is required for T-cell activation. The first step re-in the central region of .80% of junctions (Figure 8B).
In these junctions the CD2 clusters are surrounded by quires the adhesion molecules LFA-1 and CD2 to medi-
ate an initial transient interaction (Shaw et al., 1986).areas of LFA-1/ICAM-1±mediated contact as indicated
by IRM images. Thus, antigen receptor engagement is This initial adhesive interaction facilitates engagement
Figure 8. Requirement of Antigen Receptor
Engagement for Receptor Patterning
T cells from 3A9 TCR transgenic mice were
incubated with bilayers containing 500 mo-
lec/mm2 ICAM-1 and 300 molec/mm2 FITC-
CD48 without or with antigen I-AkzHEL48±62
at 50 molec/mm2. The accumulation of CD48
was determined by fluorescence microscopy
and represented with the indicated color
scale. In the absence of antigen, many fewer
cells were able to adhere to the bilayer. In the
figure, CD48 accumulation is superimposed
on the grayscale IRM. The dark gray areas in
IRM represent regions of LFA-1/ICAM-1 ad-
hesion. The average accumulation of CD48
in the absence and presence of antigen is




of theTCR by peptides bound toMHC. TCR engagement CD2 clustering in the central region of the junction.
These data are consistent with earlier reports that anti-leads to suppression of T-cell locomotion, formation of
a specialized junction, and T-cell polarization (Kupfer gen receptor engagement regulates CD2 avidity (Hahn
et al., 1992) and with studies demonstrating that T-celland Singer, 1989; Dustin et al., 1997a). This combination
of a specialized junction, cell polarization,and positional polarization is mediated primarily by TCR engagement
(Kupfer et al., 1986; Lowin-Kropf et al., 1998). Our resultsstability bears a striking similarity to the classical syn-
apse of the nervous system (Paul and Seder, 1994). The directly demonstrate antigen-regulated CD2/CD48 in-
teractions. We suspect that the small amounts of CD2ªimmunological synapseº is characterized by a specific
pattern of molecules in the contact; LFA-1 is localized engagement detected in the absence of antigen allow
the TCRto scan for MHC-peptide complexes in the smallto the periphery of the contact while the TCR and acces-
sory molecules like CD2, CD4, and CD28 are localized 15 nm contact areas. Recognition of thecorrect peptide/
MHC complex by a TCR would then result in a chainto the center of the contact.
The orchestrated receptor movements that character- of events leading to T-cell activation. Increased LFA-1
avidity and CD2 clusteringwould result in immunologicalize formation of the immunological synapse have two
key features: (1) segregation of surface molecules into synapse formation. Synapse formation would allow the
rare specific peptide/MHC complex to serially triggera least two domains and (2) the localization of one group
of molecules in a central cluster. Here we have identified multiple TCRs (Valitutti et al., 1995).
The structure of CD2AP supports an important rolesome of the mechanisms for molecular segregation and
for CD2AP in contact formation and polarization. Information of the central cluster.
yeast, the protein BEM1, which contains two amino-Recently, we proposed that the forces that govern
terminal SH3 domains, is required for cell polarizationcontact cap formation are likely to include the size of
(Chenevert et al., 1992). It functions by organizing thethe molecules involved (Shaw and Dustin, 1997). This
cytoskeleton around the polarized site where buddingwas based on the fact that the molecules that occupy
will take place (Peterson et al., 1994). Thus, BEM1 isthe central region of the immunological synapse share
thought to link membrane proteins that mark the sitea common topology. Structural data indicate that the
of polarization with the cytoskeleton. The binding ofinteraction of TCR with MHC, CD2 with CD48, CD28
CD2AP to CD2 in the contact area may play an analo-with CD80, and CD4 or CD8 with MHC all span a gap
gous role.of 15 nm. In contrast, the LFA-1/ICAM-1 interaction is
Although T cells from mice lacking CD2 do not exhibitpredicted to span z30±40 nm (Staunton et al., 1990). In
a significant phenotype (Kileen et al., 1992), the simplestfact, ICAM-1 alone is z20 nm long, too large to be easily
explanation is that another molecule can compensateaccommodated in the 15 nm gap. These theoretical ar-
for the loss of CD2. We would favor that other moleculesguments, however, had yet to be tested experimentally.
that are topologically similar in size to CD2, like CD28,Here, we demonstrated that ICAM-1 is strongly ex-
could share some functions with CD2. In addition, thecluded from CD2/CD48-mediated contact areas. This
powerful role of thymus selection would allow the gener-exclusion is probably related to the difference inmolecu-
ation of T cells that are adapted to depend on otherlar size between CD2/CD48 and ICAM/LFA-1, support-
molecules that share function of CD2.ing a simple biophysical mechanism for initial protein
Our model suggests that T-cell engagement of thesegregation and for the exclusion of large molecules
APC is first mediated by LFA-1 and CD2 in distinct do-like CD45 and CD43 from contact areas. Because the
mains of non-antigen-specific contact areas. Engage-ability of the CD2/CD48 interaction to exclude ICAM-1
ment of TCR stimulates the binding of CD2AP to CD2was not dependent on the cytoplasmic tail of CD2, ex-
and enhances the avidity of LFA-1 leading to formationclusion and segregation are mainly the result of ectodo-
of a well-organized contact. CD2AP functions by clus-main interactions and steric considerations.
tering CD2 and possibly by marking the polarizedHere we demonstrated that the central clustering of
surface. While interaction of CD2AP is not required toCD2 was dependent on sequences contained in the last
exclude large glycoproteins from sites of CD2 engage-20 amino acids of the CD2 cytoplasmic domain. We then
ment, CD2 clustering by CD2AP will consolidate exclu-identified a protein, CD2AP, which interacts with this
sion of larger molecules like CD45, CD43, and LFA-1 byregion. CD2AP has three SH3 domains and multiple
driving these molecules to the periphery of the contactpolyproline motifs in a tandem array suggesting that it
and may also play a role in TCR recruitment to the con-functions as an adaptor protein. Support for a role for
tact. Thus, the biophysical forces that result in the orga-CD2AP in cytoskeletal rearrangement and CD2 cluster-
nization of a T-cell contact are related to protein sizeing was obtained by overexpressing a dominant-nega-
and the ability of the cytoskeleton to facilitate proteintive form of CD2AP, which blocked both CD2-triggered
clustering and concentration. The end result of this ac-cytoskeletal polarization and immunological synapse
tivity is that TCR engagement is protected in a stableformation. Central clustering of CD2 may have an impor-
central portion of the contact area. Understanding thesetant role in maintaining a stable domain for sustained
forces in greater detail will lead to a more profoundantigen receptor engagement and signaling.
understanding of the process of T-cell activation.Antigen receptor engagement is the central event in
the formation of the immunological synapse (Paul and
Experimental ProceduresSeder, 1994). Therefore, it is significant that we found
that CD2 engagement and clustering is dependent on Antibodies
antigen receptor engagement. Antigen receptor en- The MAbs, OX34 (CD2; Jefferies et al., 1985), 9E10 (Evan and Bishop,
1985), OX78 (Kato et al., 1992), YN1/1 (Takei, 1985), TS2/9 (Shaw etgagement induces CD2AP binding to CD2 resulting in
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al., 1986), RR1/1 (Dustin and Springer, 1988), CL203 (Temponi et clones isolated was approximately 2.1 kb in length. The nitrocellu-
lose membrane containing the RNA from various murine tissues wasal., 1988), CD2.1 (Olive et al., 1986), and TS2/18 (Shaw et al., 1986),
were used after purification from ascites or culture supernatants. obtained from Clontech (Palo Alto, CA).
The rabbit anti-CD2AP sera was generated against full-length
CD2AP expressed and purified from bacteria. Cell Lysates
Total protein lysates from murine brain, heart, spleen, liver, lung,
kidney, and thymus were prepared by mincing the tissues in anAdhesion Molecules
ice-cold hypotonic buffer and then homogenized using a polytron.Human CD58, mouse CD48, and human ICAM-1-GPI were affinity
Cellular debris was removed by centrifugation, and cellular proteinpurified from human erythrocytes using TS2/9 MAb, C3F6 cells using
was normalized before immunoblotting.OX78 MAb, and CHO cells using RR1/1 MAb, respectively. Each
protein was labeled while attached to the respective MAb to protect
DNA Constructs, Mutagenesis and Transfectionsthe active site. Dyes were used at 0.05 mg/ml of MAb-Sepharose.
The cDNA constructs for mapping the interaction of CD2AP withThe labeled proteins were then eluted, free dye was removed by
CD2 were constructed using PCR-based mutagenesis. Transientultrafiltration, and the protein was analyzed by SDS-PAGE. Labeled
protein expression for mapping studies was performed using themolecules retained full activity and mediated adhesion in the physio-
vaccinia-T7 expression system as previously described (Richard etlogical density range. The activity of labeled and unlabeled mole-
al., 1995). For immunoprecipitations, HeLa cells were lysed in a lysiscules was identical. I-AkHEL48±62 was purified and reconstituted
buffer containing 1% digitonin in 150 mM NaCl, 25 mM Tris-HCl (pHas described (Dustin et al., 1997a).
7.4). Immunoprecipitations were performed on cleared lysates using
2 ml of antisera. The beads were then washed with lysis buffer and
Preparation of Glass-Supported Planar Bilayers then analyzed by SDS-PAGE. Whole cell lysates were prepared by
Glass-supported planar bilayers were prepared by the method of lysing transfected cells directly with Laemmli sample buffer. For
McConnell et al. (1986). Briefly, adhesion molecules were combined immunoblotting, proteins were separated on 8% SDS-PAGE gels,
with 0.4 mM egg phosphatidylcholine (egg PC) in PBS with 1% transferred to nitrocellulose, and visualized using chemilumines-
octylglucoside and were dialyzed against PBS to form liposomes cence.
with incorporated adhesion molecules. The liposome suspensions
were incubated on a clean glass coverslip in a parallel plate flow Binding Studies and Scatchard Analysis
cell to form bilayers (Bioptechs, Butler, PA). The surface was treated Binding and affinity studies were conducted using surface plasmon
with 5% non-fat dry milk (Carnation). Adhesion experiments were resonance on a BIAcore 2000 (Pharmacia). A peptide corresponding
performed in HBS with 1 mM Mg and CaCl2 and 5% serum at 378C. All to residues 317±337 (QKGPPLPRPRVQPKPPCG) of the CD2 tailwas
adhesion was inhibited by antibodies to LFA-1 and CD2. Adhesion synthesized as previously described (Muslin et al., 1996), biotinyl-
molecule density was determined by binding of iodinated Fab frag- ated at the N terminus, and linked to a streptavidin-coated sensor
ments of MAb. ICAM-1 was reconstituted at 500 molec/mm2, human chip. SH3-GST fusion proteins at a concentration of 1 mM were
CD58 at 200 molec/mm2, mouse CD48 at 300±1000 molec/mm2, and passed over the chip at a flow rate of 5 ml/min at 158C in 50 mM
I-AkHEL48±62 at 50 molec/mm2. HEPES (pH. 7.4), 150 mM NaCl, 0.001% Tween 20, 5 mM bME.
Peptide competition studies were performed to determine the exact
binding site of CD2AP on CD2. CD2AP SH3I-GST (1 mM) was incu-Microscopy
bated with 10 to 500 mM of competing peptides (QKGAPLARPImages were acquired using an inverted microscope (Yona Micro-
RVQPKPPCG, QKGPPLPRPAVQPKPPCG, QKGPPLPRPRVQAKPscopes, Silver Spring, MD and Carl Zeiss, Thornwood, NY) (Dustin
ACG) and analyzed as above. Kinetic studies were analyzed usinget al., 1997b). Filters: dichroic mirror XF93; emission filter XF93;
BIAevaluation 2.1 (Biacore AB). Scatchard analysis was performedexcitation filters XEXM2, XEXM3, XEXM4 (Omega Optical, Brat-
using CD2AP SH3-GST concentrations from 0.070 to 70 mM. Fyntleboro, VT). IRM images were obtained excitation filter XF32. Objec-
and Lck SH3-GST Scatchard analyses were performed similarly.tive: 1003 Neofluar 1.3 N.A. Camera: PXL1400 with resolution of
650 3 508 pixels 5 108 3 85 mm (Photometrics, Tuscon, AZ). Images
were processed using IP-lab software (Scanalytics, Vienna, VA). Acknowledgments
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